His highest impact factor publication in the PTCDM field is “Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an APC Gene Mutation: A Case Study”, published in “Thyroid.” This article reveals the promising potential of Lenvatinib in treating lung metastases from PTC and familial adenomatous polyposis (50). Here, APC is linked to thyroid gland papillary carcinoma.